Philippine Health Research Registry
Display Options
Results List
Results 1 - 4 of 4 Aida Muncada, MD research(es)

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Ongoing
Project Description:
This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of 2 fixed doses of lurasidone (40 mg and 80 mg/day) for 6 weeks compared with placebo in adolescent subjects with acute schizophrenia. Subjects will be evaluated for eligibility during a screening period of up to 21 days, during whic... [read more]
Project Status:
Ongoing
Project Description:
This is an open-label, 104-week, multicenter, extension study designed to evaluate the long-term safety, tolerability and effectiveness of flexibly dosed lurasidone (20, 40, 60 or 80 mg/day) in pediatric subjects who have completed the 6-week treatment period in the preceding studies, D1050301 or D1050325. All eligible subjects will be treated with... [read more]
Project Status:
Ongoing
Project Description:
This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of flexibly dosed lurasidone (20 - 80 mg/day) for 6 weeks compared with placebo in children and adolescent subjects with depression associated with Bipolar I Disorder (bipolar depression).This study involves screening phase, randomiza... [read more]
Project Status:
Ongoing
Project Description:
The study consists of 4 phases: the washout phase, the double-blind treatment phase, the open-label treatment phase, and the follow-up phase. The double-blind treatment phase is conducted in a multicenter, randomized, double-blind, placebo-controlled, parallel-group manner.   In the washout phase, placebo will be applied once daily for 1 week (at ... [read more]